Iktos Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
71
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
14
Iktos General Information
Description
Developer of a drug discovery platform that combines generative AI and robotics to address inefficiencies in traditional drug development processes. The company's platform specializes in artificial intelligence and robotics applied to research in medicinal chemistry and new drug design, applied to chemical research, specifically medicinal chemistry, and new drug design developed several proprietary and innovative systems based on AI, helping researchers to identify drug candidates in their research and development program.
Contact Information
Website
www.iktos.aiCorporate Office
- 65 rue de Prony
- 75017 Paris
- France
Corporate Office
- 65 rue de Prony
- 75017 Paris
- France
Iktos Timeline
Iktos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 13. Accelerator/Incubator | 06-Nov-2025 | Completed | Generating Revenue | |||
| 12. Grant | 20-Feb-2025 | Completed | Generating Revenue | |||
| 11. Later Stage VC | Cancelled | Generating Revenue | ||||
| 10. Later Stage VC (Series A) | 09-Mar-2023 | Completed | Generating Revenue | |||
| 9. Grant | 30-Nov-2021 | Completed | Generating Revenue | |||
| 8. Early Stage VC | 14-Jun-2019 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 12-Mar-2018 | Completed | Generating Revenue | |||
| 6. Grant | 01-Mar-2018 | $1.11M | $799K | Completed | Generating Revenue | |
| 5. Accelerator/Incubator | 01-Jan-2018 | $799K | Completed | Startup |
Iktos Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Iktos Comparisons
Industry
Financing
Details
Iktos Competitors (3)
One of Iktos’s 3 competitors is InSilico Medicine Cayman, a Formerly VC-backed company based in Hong Kong, Hong Kong.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| InSilico Medicine Cayman | Formerly VC-backed | Hong Kong, Hong Kong | ||||
| Exscientia | Formerly VC-backed | Oxford, United Kingdom | ||||
| Numerion Labs | Venture Capital-Backed | San Francisco, CA |
Iktos Patents
Iktos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026132447-A1 | Polycyclic mthfd2 inhibitors and uses thereof | Pending | 20-Dec-2024 | ||
| WO-2026083123-A1 | Coupling a 3d generative model to a constrained conformation optimization module in a global reinforcement loop | Pending | 18-Oct-2024 | ||
| EP-4459287-A1 | Methods and tools for detecting the impact of compounds on protein, rna or dna interactions | Pending | 02-May-2023 | ||
| US-20260309718-A1 | Methods and tools for detecting the impact of compounds on protein, rna or dna interactions | Pending | 02-May-2023 | ||
| WO-2024227864-A1 | Methods and tools for detecting the impact of compounds on protein, rna or dna interactions | Inactive | 02-May-2023 | G01N33/6845 |
Iktos Signals
Iktos Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| La French Tech | Accelerator/Incubator | |||
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Debiopharm Innovation Fund | Corporate Venture Capital | Minority | ||
| M Ventures | Corporate Venture Capital | Minority | ||
| Omnes Capital | PE/Buyout | Minority |
Iktos Acquisitions (1)
Iktos’s most recent deal was a Merger/Acquisition with Synsight. The deal was made on 08-Jul-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Synsight | 08-Jul-2024 | Merger/Acquisition | Drug Discovery |
Iktos FAQs
-
When was Iktos founded?
Iktos was founded in 2016.
-
Where is Iktos headquartered?
Iktos is headquartered in Paris, France.
-
What is the size of Iktos?
Iktos has 71 total employees.
-
What industry is Iktos in?
Iktos’s primary industry is Drug Discovery.
-
Is Iktos a private or public company?
Iktos is a Private company.
-
What is Iktos’s current revenue?
The current revenue for Iktos is .
-
How much funding has Iktos raised over time?
Iktos has raised $21M.
-
Who are Iktos’s investors?
La French Tech, European Innovation Council, Debiopharm Innovation Fund, M Ventures, and Omnes Capital are 5 of 14 investors who have invested in Iktos.
-
Who are Iktos’s competitors?
InSilico Medicine Cayman, Exscientia, and Numerion Labs are competitors of Iktos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process